Cardiovascular risk profile and frailty in Japanese outpatients: the Nambu Cohort Study

Mitsuteru Matsuoka1, Taku Inoue2,3, Tetsuji Shinjo4

  • 1Matsuoka Clinic, Tomigusuku, Japan.

Insights

Older adults with a favorable cardiovascular risk profile, including normal blood pressure and cholesterol, are more likely to be frail. This suggests a link between cardiovascular health and physical decline in aging populations.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Epidemiology

Background:

  • Unfavorable cardiovascular (CV) risk profiles, such as elevated systolic blood pressure (SBP) and low-density lipoprotein cholesterol (LDL-C), are known to decelerate with aging.
  • The association between CV risk profiles and frailty, a state of increased vulnerability, has been underexplored in aging populations.
  • Frailty is a significant concern in geriatric care, impacting health outcomes and healthcare utilization.

Purpose of the Study:

  • To investigate the relationship between cardiovascular risk factors and the prevalence of frailty in an elderly outpatient cohort.
  • To determine if specific CV risk factors (SBP, LDL-C, BMI) or a composite CV risk score are associated with frailty.
  • To explore potential mechanisms, such as 'reverse metabolic syndrome,' linking CV health and frailty.

Main Methods:

  • Cross-sectional analysis of baseline data from a prospective cohort study.
  • Inclusion of 599 subjects aged 70-83 years.
  • Frailty assessment using the Kihon Checklist; CV risk factors (SBP, LDL-C, BMI) were measured.

Main Results:

  • Frailty was diagnosed in 37% of the participants.
  • An unfavorable CV risk profile was paradoxically associated with a lower risk of frailty.
  • Higher SBP (OR 0.83) and BMI (OR 1.03) showed trends towards lower frailty risk, while LDL-C (OR 0.96) did not significantly correlate.
  • Having more CV risk factors within the optimal range significantly increased the odds of frailty (e.g., 3 factors: OR 4.79).

Conclusions:

  • A favorable cardiovascular risk profile, characterized by optimal levels of SBP, LDL-C, and BMI, is associated with an increased risk of frailty in older adults.
  • This counterintuitive finding suggests a potential 'reverse metabolic syndrome' phenomenon in frail elderly individuals.
  • Further research is needed to elucidate the complex interplay between cardiovascular health, metabolic status, and frailty in aging.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
141
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
537
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
142
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
146
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
190
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
461